Report Detail
Global Remifentanil Hydrochloride Market Growth 2019-2024
- RnM2930433 |
- 12 February, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
Remifentanil Hydrochloride is a kind of high-end opioid analgesic, it can used in the maintain analgesia and anesthesia induction of general anesthesia, it has the feature of working fast, no accumulate in the body, blood and drug concentration smooth, short duration of action, strong analgesic potency, recover quickly after using, light adverse reactions and so on.
The global remifentanil hydrochloride company mainly concentrates in the developed countries, the consumption groups also concentrate in the developed countries and the high income people.
The Europe remifentanil hydrochloride industry is mainly concentrated in the UK and Germany, it has a high degree of industrial concentration, it is mainly due to the patent and the technology monopoly, the UK and Germany has the highest production and consumption, the consumption groups are mainly higher income levels due to the high price.
The remifentanil hydrochloride is produced in the developed countries, so the import and export are between developing countries and developed countries. The remifentanil hydrochloride has relative high growth rate and the gross margin is about 80%.
According to this study, over the next five years the Remifentanil Hydrochloride market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Remifentanil Hydrochloride business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Remifentanil Hydrochloride market by product type, application, key manufacturers and key regions and countries.
This study considers the Remifentanil Hydrochloride value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Endotracheal intubation operation
Neurosurgery
Outpatient surgery
Postoperative analgesia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Remifentanil Hydrochloride consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Remifentanil Hydrochloride market by identifying its various subsegments.
Focuses on the key global Remifentanil Hydrochloride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Remifentanil Hydrochloride with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Remifentanil Hydrochloride submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Remifentanil Hydrochloride Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Remifentanil Hydrochloride Consumption 2014-2024
- 2.1.2 Remifentanil Hydrochloride Consumption CAGR by Region
- 2.2 Remifentanil Hydrochloride Segment by Type
- 2.2.1 1mg/Pcs
- 2.2.2 2mg/Pcs
- 2.2.3 5mg/Pcs
- 2.3 Remifentanil Hydrochloride Consumption by Type
- 2.3.1 Global Remifentanil Hydrochloride Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Remifentanil Hydrochloride Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Remifentanil Hydrochloride Sale Price by Type (2014-2019)
- 2.4 Remifentanil Hydrochloride Segment by Application
- 2.4.1 Endotracheal intubation operation
- 2.4.2 Neurosurgery
- 2.4.3 Outpatient surgery
- 2.4.4 Postoperative analgesia
- 2.4.5 Other
- 2.5 Remifentanil Hydrochloride Consumption by Application
- 2.5.1 Global Remifentanil Hydrochloride Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Remifentanil Hydrochloride Value and Market Share by Application (2014-2019)
- 2.5.3 Global Remifentanil Hydrochloride Sale Price by Application (2014-2019)
3 Global Remifentanil Hydrochloride by Players
- 3.1 Global Remifentanil Hydrochloride Sales Market Share by Players
- 3.1.1 Global Remifentanil Hydrochloride Sales by Players (2017-2019)
- 3.1.2 Global Remifentanil Hydrochloride Sales Market Share by Players (2017-2019)
- 3.2 Global Remifentanil Hydrochloride Revenue Market Share by Players
- 3.2.1 Global Remifentanil Hydrochloride Revenue by Players (2017-2019)
- 3.2.2 Global Remifentanil Hydrochloride Revenue Market Share by Players (2017-2019)
- 3.3 Global Remifentanil Hydrochloride Sale Price by Players
- 3.4 Global Remifentanil Hydrochloride Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Remifentanil Hydrochloride Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Remifentanil Hydrochloride Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Remifentanil Hydrochloride by Regions
- 4.1 Remifentanil Hydrochloride by Regions
- 4.1.1 Global Remifentanil Hydrochloride Consumption by Regions
- 4.1.2 Global Remifentanil Hydrochloride Value by Regions
- 4.2 Americas Remifentanil Hydrochloride Consumption Growth
- 4.3 APAC Remifentanil Hydrochloride Consumption Growth
- 4.4 Europe Remifentanil Hydrochloride Consumption Growth
- 4.5 Middle East & Africa Remifentanil Hydrochloride Consumption Growth
5 Americas
- 5.1 Americas Remifentanil Hydrochloride Consumption by Countries
- 5.1.1 Americas Remifentanil Hydrochloride Consumption by Countries (2014-2019)
- 5.1.2 Americas Remifentanil Hydrochloride Value by Countries (2014-2019)
- 5.2 Americas Remifentanil Hydrochloride Consumption by Type
- 5.3 Americas Remifentanil Hydrochloride Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Remifentanil Hydrochloride Consumption by Countries
- 6.1.1 APAC Remifentanil Hydrochloride Consumption by Countries (2014-2019)
- 6.1.2 APAC Remifentanil Hydrochloride Value by Countries (2014-2019)
- 6.2 APAC Remifentanil Hydrochloride Consumption by Type
- 6.3 APAC Remifentanil Hydrochloride Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Remifentanil Hydrochloride by Countries
- 7.1.1 Europe Remifentanil Hydrochloride Consumption by Countries (2014-2019)
- 7.1.2 Europe Remifentanil Hydrochloride Value by Countries (2014-2019)
- 7.2 Europe Remifentanil Hydrochloride Consumption by Type
- 7.3 Europe Remifentanil Hydrochloride Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Remifentanil Hydrochloride by Countries
- 8.1.1 Middle East & Africa Remifentanil Hydrochloride Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Remifentanil Hydrochloride Value by Countries (2014-2019)
- 8.2 Middle East & Africa Remifentanil Hydrochloride Consumption by Type
- 8.3 Middle East & Africa Remifentanil Hydrochloride Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Remifentanil Hydrochloride Distributors
- 10.3 Remifentanil Hydrochloride Customer
11 Global Remifentanil Hydrochloride Market Forecast
- 11.1 Global Remifentanil Hydrochloride Consumption Forecast (2019-2024)
- 11.2 Global Remifentanil Hydrochloride Forecast by Regions
- 11.2.1 Global Remifentanil Hydrochloride Forecast by Regions (2019-2024)
- 11.2.2 Global Remifentanil Hydrochloride Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Remifentanil Hydrochloride Forecast by Type
- 11.8 Global Remifentanil Hydrochloride Forecast by Application
12 Key Players Analysis
- 12.1 GSK
- 12.1.1 Company Details
- 12.1.2 Remifentanil Hydrochloride Product Offered
- 12.1.3 GSK Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GSK News
- 12.2 Macfarlan Smith
- 12.2.1 Company Details
- 12.2.2 Remifentanil Hydrochloride Product Offered
- 12.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Macfarlan Smith News
- 12.3 Abbott
- 12.3.1 Company Details
- 12.3.2 Remifentanil Hydrochloride Product Offered
- 12.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Abbott News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Remifentanil Hydrochloride Product Offered
- 12.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
- 12.5 Arevipharma
- 12.5.1 Company Details
- 12.5.2 Remifentanil Hydrochloride Product Offered
- 12.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Arevipharma News
- 12.6 AMRI
- 12.6.1 Company Details
- 12.6.2 Remifentanil Hydrochloride Product Offered
- 12.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 AMRI News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Remifentanil Hydrochloride . Industry analysis & Market Report on Remifentanil Hydrochloride is a syndicated market report, published as Global Remifentanil Hydrochloride Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Remifentanil Hydrochloride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
